MAI Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

MAI Capital Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-111	Closed	-$4.47K	–	2235
2026 Q1	$4.47K	Buy	+111	New	+$2.39K	﹤0.01%	3576

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MAI Capital Management's APLS Position: Q2 2026 in Review

MAI Capital Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 111 shares — an estimated $4.47K sold.

MAI Capital Management first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $4.47K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

MAI Capital Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
MAI Capital Management sold 111 Apellis Pharmaceuticals shares in Q2 2026, an estimated $4.47K.
MAI Capital Management first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
MAI Capital Management's Apellis Pharmaceuticals position peaked at $4.47K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.